Pharma Focus Asia

National Resilience Invests US$225 million to Increase Cartridge Fill/Finish Capabilities in Cincinnati, USA

Introduction:

National Resilience plans to invest US$225 million to increase PFS and Cartridge fill/finish capabilities in Cincinnati, USA.

Features:

The facility aims to enhance its existing fill/finish capabilities by increasing its capacity for pre-filled syringes (PFS) and cartridge fill/finish. 

The facility possesses expertise in handling drug substance and drug product for Gene Therapy medications. Additionally, it has 45,000 square feet of unused space, which can be utilised for further expansion, particularly in drug product operations.

The capacity provides over 200 million units to partners across its manufacturing network by 2025, supporting various modalities and therapeutic indications, including GLP-1.

As part of its expansion strategy, the facility will install a new cutting-edge Bausch & Strobel Isolator filler to accommodate Vials and PFS, ensuring flexibility and maintaining quality standards through its barrier isolation technology.

This expansion meets the increasing demand within the biomanufacturing industry's drug product sector, effectively meeting the evolving needs of the industry.

Moreover, the facility is expanding its drug product capabilities at the RTP facility in North Carolina by employing a modular design within its segregated expansion space. This approach aims to facilitate drug product manufacturing across multiple modalities.

The new drug product site is expected to be opened by 2025.

Specifications:

Name       National Resilience
Type         New Construction
Budget    US$225 million
Year          2025


 

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference